Gene expression in skeletal muscle after an acute intravenous GH bolus in human subjects: Identification of a mechanism regulating ANGPTL4

Journal of Lipid Research

Volumn 54, Issue 7, 2013, Pages 1988-1997

  Clasen, Berthil F F ^a   Krusenstjerna Hafstrmø, Thomas ^a   Vendelbo, Mikkel Holm ^a   Thorsen, Kasper ^a   Escande, Carlos ^b   Moøller, Niels ^a   Pedersen, Steen B ^a   Jørgensen, Jens Otto L ^a   Jessen, Niels ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

Angiopoietin related protein like 4; Growth hormone; Human gene array; Lipid metabolism

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN RELATED PROTEIN LIKE 4; CYTOKINE INDUCIBLE SH2 CONTAINING PROTEIN; FATTY ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN 1A; INSULIN; JANUS KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE CLASS 2B; PROTEIN SH2; RECOMBINANT GROWTH HORMONE; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANGPTL4 GENE; ANIMAL CELL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME REPRESSION; FATTY ACID BLOOD LEVEL; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC CODE; GROWTH HORMONE DEFICIENCY; HUMAN; HUMAN TISSUE; LIPOLYSIS; MALE; MICROARRAY ANALYSIS; MOUSE; MUSCLE BIOPSY; NFKB1A GENE; NONHUMAN; PIK3C2B GENE; PRIORITY JOURNAL; PRKAG2 GENE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANGIOPOIETIN-RELATED PROTEIN-LIKE 4; GROWTH HORMONE; HUMAN GENE ARRAY; LIPID METABOLISM;

ADMINISTRATION, INTRAVENOUS; ANGIOPOIETINS; CELLS, CULTURED; GENE EXPRESSION PROFILING; GROWTH HORMONE; HUMANS; MUSCLE, SKELETAL; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84878997435     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P034520     Document Type: Article

References (47)

1. Møller, N., and J. O. Jørgensen. 2009. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30: 152-177.
2. Møller, N., J. O. Jørgensen, O. Schmitz, J. Møller, J. Christiansen, K. G. Alberti, and H. Ørskov. 1990. Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am. J. Physiol. 258: E86-E91. (Pubitemid 20068583)
3. Merkel, M., R. H. Eckel, and I. J. Goldberg. 2002. Lipoprotein lipase: genetics, lipid uptake, and regulation. J. Lipid Res. 43: 1997-2006. (Pubitemid 35471065)
4. Richelsen, B., S. B. Pedersen, K. Kristensen, J. D. Børglum, H. Nørrelund, J. S. Christiansen, and J. O. Jørgensen. 2000. Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism. 49: 906-911. (Pubitemid 30483445)
5. Nikkila, E. A., and R. Pelkonen. 1975. Serum lipids in acromegaly. Metabolism. 24: 829-838.
6. Krag, M. B., L. C. Gormsen, Z. Guo, J. S. Christiansen, M. D. Jensen, S. Nielsen, and J. O. Jørgensen. 2007. Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics. Am. J. Physiol. Endocrinol. Metab. 292: E920-E927. (Pubitemid 46411073)
7. Nielsen, S., N. Møller, J. S. Christiansen, and J. O. Jørgensen. 2001. Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes. 50: 2301-2308. (Pubitemid 33641915)
8. Dominici, F. P., D. P. Argentino, M. C. Munoz, J. G. Miquet, A. I. Sotelo, and D. Turyn. 2005. Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth Horm. IGF Res. 15: 324-336. (Pubitemid 41403767)
9. del Rincon, J. P., K. Iida, B. D. Gaylinn, C. E. McCurdy, J. W. Leitner, L. A. Barbour, J. J. Kopchick, J. E. Friedman, B. Draznin, and M. O. Thorner. 2007. Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes. 56: 1638-1646. (Pubitemid 46842597)
10. Krusenstjerna-Hafstrøm, T., B. F. Clasen, N. Møller, N. Jessen, S. B. Pedersen, J. S. Christiansen, and J. O. Jørgensen. 2011. Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults. J. Clin. Endocrinol. Metab. 96: 2548-2557.
11. Nielsen, C., L. C. Gormsen, N. Jessen, S. B. Pedersen, N. Møller, S. Lund, and J. O. Jørgensen. 2008. Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade. J. Clin. Endocrinol. Metab. 93: 2842-2850. (Pubitemid 352008560)
12. Jessen, N., C. B. Djurhuus, J. O. Jørgensen, L. S. Jensen, N. Møller, S. Lund, and O. Schmitz. 2005. Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion. Am. J. Physiol. Endocrinol. Metab. 288: E194-E199. (Pubitemid 40023807)
13. Krusenstjerna-Hafstrøm, T., M. Madsen, M. H. Vendelbo, S. B. Pedersen, J. S. Christiansen, N. Møller, N. Jessen, and J. O. Jørgensen. 2011. Insulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose load. PLoS ONE. 6: e19392.
14. Jørgensen, J. O., N. Jessen, S. B. Pedersen, E. Vestergaard, L. Gormsen, S. A. Lund, and N. Billestrup. 2006. GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus. Am. J. Physiol. Endocrinol. Metab. 291: E899-E905.
15. Vestergaard, E. T., L. C. Gormsen, N. Jessen, S. Lund, T. K. Hansen, N. Møller, and J. O. Jørgensen. 2008. Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes. 57: 3205-3210.
16. Vendelbo, M. H., J. O. Jørgensen, S. B. Pedersen, L. C. Gormsen, S. Lund, O. Schmitz, N. Jessen, and N. Møller. 2010. Exercise and fasting activate growth hormone-dependent myocellular signal transducer and activator of transcription-5b phosphorylation and insulin-like growth factor-I messenger ribonucleic acid expression in humans. J. Clin. Endocrinol. Metab. 95: E64-E68.
17. Cesena, T. I., T. X. Cui, G. Piwien-Pilipuk, J. Kaplani, A. A. Calinescu, J. S. Huo, J. A. Iniguez-Lluhi, R. Kwok, and J. Schwartz. 2007. Multiple mechanisms of growth hormone-regulated gene transcription. Mol. Genet. Metab. 90: 126-133. (Pubitemid 46108616)
18. Sadowski, C. L., T. T. Wheeler, L. H. Wang, and H. B. Sadowski. 2001. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells. Endocrinology. 142: 3890-3900. (Pubitemid 32802661)
19. Sadowski, C. L., T. S. Choi, M. Le, T. T. Wheeler, L. H. Wang, and H. B. Sadowski. 2001. Insulin induction of SOCS-2 and SOCS-3 mRNA expression in C2C12 skeletal muscle cells is mediated by Stat5*. J. Biol. Chem. 276: 20703-20710.
20. Sjögren, K., K. C. Leung, W. Kaplan, M. Gardiner-Garden, J. Gibney, and K. K. Ho. 2007. Growth hormone regulation of metabolic gene expression in muscle: a microarray study in hypopituitary men. Am. J. Physiol. Endocrinol. Metab. 293: E364-E371. (Pubitemid 47105952)
21. Flores-Morales, A., N. Stahlberg, P. Tollet-Egnell, J. Lundeberg, R. L. Malek, J. Quackenbush, N. H. Lee, and G. Norstedt. 2001. Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat. Endocrinology. 142: 3163-3176. (Pubitemid 32577105)
22. Viguerie, N., K. Clement, P. Barbe, M. Courtine, A. Benis, D. Larrouy, B. Hanczar, V. Pelloux, C. Poitou, Y. Khalfallah, et al. 2004. In vivo epinephrine-mediated regulation of gene expression in human skeletal muscle. J. Clin. Endocrinol. Metab. 89: 2000-2014. (Pubitemid 38619824)
23. Ge, H., G. Yang, L. Huang, D. L. Motola, T. Pourbahrami, and C. Li. 2004. Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J. Biol. Chem. 279: 2038-2045. (Pubitemid 38084475)
24. Kersten, S., L. Lichtenstein, E. Steenbergen, K. Mudde, H. F. Hendriks, M. K. Hesselink, P. Schrauwen, and M. Muller. 2009. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler. Thromb. Vasc. Biol. 29: 969-974.
25. Lichtenstein, L., and S. Kersten. 2010. Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1. Biochim. Biophys. Acta. 1801: 415-420.
26. Adachi, H., T. Kondo, G. Y. Koh, A. Nagy, Y. Oike, and E. Araki. 2011. Angptl4 deficiency decreases serum triglyceride levels in lowdensity lipoprotein receptor knockout mice and streptozotocininduced diabetic mice. Biochem. Biophys. Res. Commun. 409: 177-180.
27. Romeo, S., L. A. Pennacchio, Y. Fu, E. Boerwinkle, A. Tybjaerg-Hansen, H. H. Hobbs, and J. C. Cohen. 2007. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat. Genet. 39: 513-516. (Pubitemid 46514768)
28. Sanderson, L. M., T. Degenhardt, A. Koppen, E. Kalkhoven, B. Desvergne, M. Muller, and S. Kersten. 2009. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver. Mol. Cell. Biol. 29: 6257-6267.
29. Yoon, J. C., T. W. Chickering, E. D. Rosen, B. Dussault, Y. Qin, A. Soukas, J. M. Friedman, W. E. Holmes, and B. M. Spiegelman. 2000. Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol. Cell. Biol. 20: 5343-5349. (Pubitemid 30431587)
30. Kersten, S., S. Mandard, N. S. Tan, P. Escher, D. Metzger, P. Chambon, F. J. Gonzalez, B. Desvergne, and W. Wahli. 2000. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 275: 28488-28493.
31. Kliewer, S. A., S. S. Sundseth, S. A. Jones, P. J. Brown, G. B. Wisely, C. S. Koble, P. Devchand, W. Wahli, T. M. Willson, J. M. Lenhard, et al. 1997. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. USA. 94: 4318-4323. (Pubitemid 27194239)
32. Staiger, H., C. Haas, J. Machann, R. Werner, M. Weisser, F. Schick, F. Machicao, N. Stefan, A. Fritsche, and H. U. Haring. 2009. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes. 58: 579-589.
33. Hessvik, N. P., S. S. Bakke, K. Fredriksson, M. V. Boekschoten, A. Fjorkenstad, G. Koster, M. K. Hesselink, S. Kersten, E. T. Kase, A. C. Rustan, et al. 2010. Metabolic switching of human myotubes is improved by n-3 fatty acids. J. Lipid Res. 51: 2090-2104.
34. Crunkhorn, S., F. Dearie, C. Mantzoros, H. Gami, W. S. da Silva, D. Espinoza, R. Faucette, K. Barry, A. C. Bianco, and M. E. Patti. 2007. Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 282: 15439-15450. (Pubitemid 47093279)
35. Robciuc, M. R., P. Skrobuk, A. Anisimov, V. M. Olkkonen, K. Alitalo, R. H. Eckel, H. A. Koistinen, M. Jauhiainen, and C. Ehnholm. 2012. Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes. PLoS ONE. 7: e46212.
36. Resmini, E., B. Morte, E. Sorianello, E. Gallardo, N. de Luna, I. Illa, A. Zorzano, J. Bernal, and S. M. Webb. 2011. Identification of novel GH-regulated genes in C2C12 cells. Horm. Metab. Res. 43: 919-930.
37. Kawai, M., N. Namba, S. Mushiake, Y. Etani, R. Nishimura, M. Makishima, and K. Ozono. 2007. Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5BPPARgamma pathway. J. Mol. Endocrinol. 38: 19-34. (Pubitemid 46351590)
38. Basham, B., M. Sathe, J. Grein, T. McClanahan, A. D'Andrea, E. Lees, and A. Rascle. 2008. In vivo identification of novel STAT5 target genes. Nucleic Acids Res. 36: 3802-3818. (Pubitemid 351917541)
39. Herrington, J., L. S. Smit, J. Schwartz, and C. Carter-Su. 2000. The role of STAT proteins in growth hormone signaling. Oncogene. 19: 2585-2597. (Pubitemid 30339214)
40. Flores-Morales, A., C. J. Greenhalgh, G. Norstedt, and E. Rico-Bautista. 2006. Negative regulation of growth hormone receptor signaling. Mol. Endocrinol. 20: 241-253. (Pubitemid 43152501)
41. Verdier, F., R. Rabionet, F. Gouilleux, C. Beisenherz-Huss, P. Varlet, O. Muller, P. Mayeux, C. Lacombe, S. Gisselbrecht, and S. Chretien. 1998. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B. Mol. Cell. Biol. 18: 5852-5860. (Pubitemid 28450536)
42. Ram, P. A., and D. J. Waxman. 1999. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J. Biol. Chem. 274: 35553-35561. (Pubitemid 129512851)
43. Mathews, L. S., G. Norstedt, and R. D. Palmiter. 1986. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc. Natl. Acad. Sci. USA. 83: 9343-9347. (Pubitemid 17223357)
44. Chia, D. J., and P. Rotwein. 2010. Defining the epigenetic actions of growth hormone: acute chromatin changes accompany GHactivated gene transcription. Mol. Endocrinol. 24: 2038-2049.
45. Falasca, M., and T. Maffucci. 2012. Regulation and cellular functions of class II phosphoinositide 3-kinases. Biochem. J. 443: 587-601.
46. Zhao, J. T., M. J. Cowley, P. Lee, V. Birzniece, W. Kaplan, and K. K. Ho. 2011. Identification of novel GH-regulated pathway of lipid metabolism in adipose tissue: a gene expression study in hypopituitary men. J. Clin. Endocrinol. Metab. 96: E1188-E1196.
47. Abbot, E. L., J. G. McCormack, C. Reynet, D. G. Hassall, K. W. Buchan, and S. J. Yeaman. 2005. Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells. FEBS J. 272: 3004-3014. (Pubitemid 40904688)